PATENT REGISTER | |||||||||||||||||||||
A Supplementary Protection Certificate (SPC) exists for this Patent. To view the SPC Details click following SPC number(s): 2019/010 | |||||||||||||||||||||
Status | Granted | Patent No. | 2727918 | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Application No. | 14152945.3 | Date of Filing | 27/08/2010 | ||||||||||||||||||
Date Grant Published | 12/10/2016 | Application Published | 07/05/2014 | ||||||||||||||||||
Title of Invention | Compounds and Compositions as Protein Kinase Inhibitors | ||||||||||||||||||||
Priority |
|
||||||||||||||||||||
Inventors |
Huang, Shenlin Jin, Xianming Liu, Zuosheng Poon, Daniel Tellew, John Wan, Yongqin Wang, Xing Xie, Yongping |
||||||||||||||||||||
Current Proprietor |
Array Biopharma Inc. 3200 Walnut Street Boulder, CO 80301 UNITED STATES OF AMERICA |
||||||||||||||||||||
Address for service |
F.F. GORMAN & CO. 15 Clanwilliam Square Dublin 2 IRELAND |
||||||||||||||||||||
Renewal Fees |
|
||||||||||||||||||||
Earlier Application No. 10748211.9 | Granted | ||||||||||||||||||||
Publication Language | English | ||||||||||||||||||||
Translation Received Date | |||||||||||||||||||||
17/11/2016 | Divisional Application number: 16193400.5 Date of receipt: 11/10/2016 | ||||||||||||||||||||
09/01/2017 | Address for Service recorded as F.F. GORMAN & CO., 15 Clanwilliam Square, Dublin 2, Ireland received on 30/12/2016. | ||||||||||||||||||||
08/06/2018 | By virtue of a Licence dated 03/12/2015 PIERRE FABRE MEDICAMENT, 45 Place Abel Gance, 92100 Boulogne-Billancourt, France, have been registered as exclusive licensee and is limited to the component "Encorafenib". | ||||||||||||||||||||
01/03/2019 | Request for grant a Supplementary Protection Certificate, citing Patent number 2727918 as the relevant basic patent, in respect of the product Combination of binimetinib and encorafenib, each in all forms protected by the basic patent filed on 20/02/2019. Reference number of request is 2019/010. | ||||||||||||||||||||
28/01/2021 | Request for grant of Supplementary Protection Certification No. 2019/010 rejected in respect of Article 10(2) of Regulation (EC) No. 469/2009 |